Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells

Journal of Cellular Physiology

Volumn 229, Issue 9, 2014, Pages 1292-1300

  Hassanian, Seyed Mahdi ^a   Dinarvand, Peyman ^a   Rezaie, Alireza R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; THROMBIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD CLOTTING; CELL ADHESION; CELL ADHESION ASSAY; CELL FRACTIONATION; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ADENOSINE A2 RECEPTOR ANTAGONISTS; BLOOD COAGULATION; CAPILLARY PERMEABILITY; CELL ADHESION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; E-SELECTIN; ENZYME ACTIVATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; PROTEIN TRANSPORT; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; THROMBIN; TRANSFECTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84901236503     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24568     Document Type: Article

References (27)

1. Adair TH. 2004. An emerging role for adenosine in angiogenesis. Hypertension 44:618-620.
2. Anwar KN, Fazal F, Malik AB, Rahman A. 2004. RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65. J immunol 173:6965-6972.
3. Bae JS, Yang L, Manithody C, Rezaie AR. 2007. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood 110:3909-3916.
4. Bae JS, Rezaie AR. 2011. Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 118:3952-3959.
5. Bae JS, Rezaie AR. 2008. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost 100:101-109.
6. Bae JS, Rezaie AR. 2009. Thrombin inhibits nuclear factor kappaB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C. Thromb haemost 101:513-520.
7. Beckers CM, van Hinsbergh VW, van Nieuw Amerongen GP. 2010. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 103:40-55.
8. Chen JF, Eltzschig HK, Fredholm BB. 2013. Adenosine receptors as drug targets-What are the challenges?. Nat Rev Drug Discov 12:265-286.
9. Coughlin SR. 2005. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3:1800-1814.
10. Ely SW, Berne RM. 1992. Protective effects of adenosine in myocardial ischemia. Circulation 85:893-904.
11. Eltzschig HK, Sitkovsky MV, Robson SC. 2012. Purinergic signaling during inflammation. N Engl J Med 367:2322-2333.
12. Esmon CT. 2013. Molecular circuits in thrombosis and inflammation. Thromb Haemost 109:416-420.
13. Feistritzer C, Riewald M. 2005. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 105:3178-3184.
14. Gunther GR, Herring MB. 1991. Inhibition of neutrophil superoxide production by adenosine released from vascular endothelial cells. Ann Vasc Surg 5:325-330.
15. Hasko G, Cronstein BN. 2004. Adenosine: An endogenous regulator of innate immunity. Trends Immunol 25:33-39.
16. Johnston-Cox HA, Koupenova M, Ravid K. 2012. A2 adenosine receptors and vascular pathologies. Arterioscler Thromb Vasc Biol 32:870-878.
17. Joyce DE, Gelbert L, Ciaccia A, DeFoff B, Grinnell BW. 2001. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276:11199-11203.
18. Linden J. 2006. New insights into the regulation of inflammation by adenosine. J Clin Invest 116:1835-1837.
19. Lotze MT, Tracey KJ. 2005. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331-342.
20. Mosnier LO, Zlokovic BV, Griffin JH. 2007. The cytoprotective protein C pathway. Blood 109:3161-3172.
21. Pearson JD, Gordon JL. 1979. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature 281:384-386.
22. Rahman A, Anwar KN, True AL, Malik AB. 1999. Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J Immunol 162:5466-5476.
23. Ralevic V, Burnstock G. 1998. Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
24. Ridley AJ. 2001. Rho proteins: Linking signaling with membrane trafficking. Traffic 2:303-310.
25. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. 2002. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296:1880-1882.
26. Ruf W, Dorfleutner A, Riewald M. 2003. Specificity of coagulation factor signaling. J Thromb Haemost 1:1495-1503.
27. Spindler V, Schlegel N, Waschke J. 2010. Role of GTPases in control of microvascular permeability. Cardiovasc Res 87:243-253.